TRIB3 promotes hepatocellular carcinoma growth and predicts poor prognosis

被引:17
|
作者
Wang, Xiao-Jun [1 ]
Li, Fei-Fei [2 ]
Zhang, Yi-Jing [1 ]
Jiang, Man [1 ]
Ren, Wan-Hua [2 ]
机构
[1] Shandong First Med Univ, Dept Geriatr, Dept Geriatr Gastroenterol, Shandong Prov Hosp, Jinan, Shandong, Peoples R China
[2] Shandong First Med Univ, Dept Infect Dis, Shandong Prov Hosp, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China
关键词
TRIB3; growth; hepatocellular carcinoma; prognosis; SUPPRESSES PROLIFERATION; CELLS; APOPTOSIS; INVASION; CANCER;
D O I
10.3233/CBM-201577
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Tribbles pseudokinase 3 (TRIB3) is a member of the tribbles-related family, which is involved a lot of cellular processes and multiple cancers, such as breast cancer, colorectal cancer, renal cell carcinomas, and lung cancer. However, the expression pattern and biological function of TRIB3 in hepatocellular carcinoma (HCC) has not yet been completely elucidated. METHODS: The expression of TRIB3 and clinicopathological characteristics were evaluated by HCC tissue microarray and qPCR analysis. Lentivirus packaging and transfection were employed to establish cell lines with TRIB3 overexpression or knockdown. The biological functions of TRIB3 in the growth of HCC were determined using MTT and crystal violet assays. Tumor growth was monitored in a xenograft model in vivo. RESULTS: The expression of TRIB3 was upregulated in HCC tissue samples compared to paired normal tissues in 45 patients examined by qPCR assay. TRIB3 expression was significantly correlated with HCC tumor size and prognosis in postoperative patients by analysis of the TRIB3 expression data and HCC clinical features. Forced expression of TRIB3 significantly promoted HCC growth in vitro. In contrast, downregulation of TRIB3 inhibited cell growth in vitro. Moreover, knockdown of TRIB3 suppressed tumorigenesis of HCC cells in vivo. CONCLUSION: TRIB3 promotes growth abilities of HCC cells both in vitro and in vivo and predicts poor prognosis of HCC patients, which serves as a prognostic marker and might provide a potential therapeutic candidate for patients with HCC.
引用
收藏
页码:307 / 315
页数:9
相关论文
共 50 条
  • [41] TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway
    Shen, Peng
    Zhang, Tian-Yang
    Wang, Shu-Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [42] Inhibition of stress proteins TRIB3 and STC2 potentiates sorafenib sensitivity in hepatocellular carcinoma
    Zhou, Sheng
    Xu, Huanji
    Wei, Tianhong
    HELIYON, 2023, 9 (06)
  • [43] TRIB3 promotes lung cancer progression by activating β-catenin signaling
    Zhang, Xiaochuan
    Zhong, Ning
    Li, Xing
    Chen, Min-Bin
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 863
  • [44] Serglycin (SRGN) overexpression predicts poor prognosis in hepatocellular carcinoma patients
    Lu He
    Xinke Zhou
    Chen Qu
    Yunqiang Tang
    Qiong Zhang
    Jian Hong
    Medical Oncology, 2013, 30
  • [45] Decreased expression of acetyl-CoA synthase 2 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma
    Sun, Lin
    Kong, Yinlong
    Cao, Manqing
    Zhou, Hongyuan
    Li, Huikai
    Cui, Yunlong
    Fang, Feng
    Zhang, Wei
    Li, Jiafeng
    Zhu, Xiaolin
    Li, Qiang
    Song, Tianqiang
    Zhang, Ti
    CANCER SCIENCE, 2017, 108 (07) : 1338 - 1346
  • [46] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Ha, Sang Yun
    Song, Dae Hyun
    Hwang, Soo Hyun
    Cho, Soo Youn
    Park, Cheol-Keun
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2015, 14 (02) : 171 - 177
  • [47] RETRACTION: Stanniocalcin 2 expression predicts poor prognosis of hepatocellular carcinoma
    Zhang, Zhen-Hai
    Wu, Ya-Guang
    Qin, Cheng-Kun
    Rong, Zhong-Hou
    Su, Zhong-Xue
    Xian, Guo-Zhe
    ONCOLOGY LETTERS, 2025, 29 (03)
  • [48] Scinderin suppresses cell proliferation and predicts the poor prognosis of hepatocellular carcinoma
    Zhou, Bin
    Chen, Tian-Wei
    Jiang, Ya-Bo
    Wei, Xu-Biao
    Lu, Chong-De
    Li, Jing-Jing
    Xie, Dong
    Cheng, Shu-Qun
    ONCOLOGY LETTERS, 2020, 19 (03) : 2011 - 2020
  • [49] CCL15 overexpression predicts poor prognosis for hepatocellular carcinoma
    Li, YueGuo
    Yu, Hai Peng
    Zhang, Peng
    HEPATOLOGY INTERNATIONAL, 2016, 10 (03) : 488 - 492
  • [50] Expression of prothymosin α predicts early recurrence and poor prognosis of hepatocellular carcinoma
    Sang Yun Ha
    Dae Hyun Song
    Soo Hyun Hwang
    Soo Youn Cho
    Cheol-Keun Park
    Hepatobiliary&PancreaticDiseasesInternational, 2015, 14 (02) : 171 - 177